GLRE
Greenlight Capital Re, Ltd.
GLRE's fundamentals are mixed, but it looks expensive: trading at 9.7x earnings, above its usual 7.5x.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
GLRE Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| N/A | |
| N/A |
GLRE's profitability is currently healthy, but its revenue is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like GLRE.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
GLRE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.1x | $8.62 | -47% |
| Fair | 7.5x | $12.69 | -22% |
| Current | 9.7x | $16.36 | โ |
| Expensive | 15x | $25.44 | +56% |
Historical ranges are pointers, not guarantees.
GLRE's PE is in its fair range at 9.7x.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
GLRE Forward outlook
There aren't enough analyst estimates for GLRE to show an outlook.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
GLRE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.69 | +$1.73 |
| Q2 2026 | $1.46 | +33% |
| Q1 2026 | $2.36 | +79% |
| Q4 2025 | $2.17 | +75% |
| Q3 2025 | -$0.04 | -102% |
| Q2 2025 | $1.10 | -46% |
| Q1 2025 | $1.32 | -58% |
| Q4 2024 | $1.24 | -50% |
GLRE has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
GLRE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $148.3M | +1.5% |
| Q2 2026 | $137.5M | -14% |
| Q1 2026 | $189.7M | -11% |
| Q4 2025 | $210.3M | +48% |
| Q3 2025 | $146.1M | -22% |
| Q2 2025 | $160.1M | -8.4% |
| Q1 2025 | $213.3M | +11% |
| Q4 2024 | $141.8M | -8.8% |
GLRE's revenue fell from its 2025 peak and has held roughly level since: $148M last quarter, up 1.5% from the same quarter a year ago.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN has the edge over GLRE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was โ82% last quarter, down 50 points from the same quarter a year ago.
GLRE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.9M | -84% |
| Q2 2026 | $31.4M | -54% |
| Q1 2026 | $37.2M | +259% |
| Q4 2025 | $100.2M | +239% |
| Q3 2025 | $31.2M | -25% |
| Q2 2025 | $68.4M | +201% |
| Q1 2025 | $10.4M | -42% |
| Q4 2024 | $29.5M | +33% |
GLRE has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was โ$2.5B over the past year, against โ$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
GLRE Net Leverage
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
GLRE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.0 | Neutral |
| Stochastic | 52.0 | Neutral |
GLRE's weekly RSI is 58 (neutral) and its Stochastic is 52 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
GLRE PE vs Financial Services Sector
| Metric | GLRE | Sector median | Relative |
|---|---|---|---|
| PE | 9.7x | 13x | 26% below |
| PE % | 58 | 63 | 5 pts below |
GLRE is trading at 9.7x earnings, a 26% discount to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | โ |
IREN has no meaningful PE right now: it lost money over the past year.
GLRE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.2 | 7.8% above |
| 20 week MA | $15.6 | 4.7% above |
| 50 week MA | $15.6 | 4.7% above |
| 100 week MA | $14.5 | 13% above |
| 200 week MA | $13.1 | 25% above |
GLRE has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
GLRE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.1 | $7.16 | -29% |
| 2021 | $7.16 | $7.40 | +3.4% |
| 2022 | $7.40 | $8.09 | +9.3% |
| 2023 | $8.09 | $11.4 | +41% |
| 2024 | $11.4 | $13.8 | +21% |
| 2025 | $13.8 | $14.4 | +4.3% |
| 2026 YTD | $14.4 | $16.4 | +13% |
GLRE has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to โ93% in 2022. It's down 52% so far in 2026.